Comprehensive Thyroid & Lung
The Archer® FusionPlex Comprehensive Thyroid and Lung (CTL) panel is a targeted next-generation sequencing (NGS) product to detect gene fusions, single-nucleotide variant (SNV), indels, splicing and gene expression in 36 genes associated with lung and thyroid cancers. This panel complements the Archer VariantPlex® CTL panel for comprehensive mutation profiling of fusions, copy number variations (CNVs) and variants.
Comprehensive Fusion Detection
AMP chemistry utilizes open-ended targeted amplification to identify gene fusions whether or not the fusion partner is known.
Detect cancer-associated isoforms and alternative splicing events.
Purpose-built for wide sample type compatibility, including low-input and degraded samples such as FFPE tissue.
Simple, Lyophilized Workflow
Easy-to-handle lyophilized reagents and a simple workflow to minimize errors and reduce turnaround time.
Input cfDNA Required
Unique Molecular On-Target %
Illumina® and Ion Torrent™
Fresh frozen and FFPE
Input recommendations for FFPE samples vary depending on Archer PreSeq® RNA QC score; 50ng input recommended in absence of PreSeq screening